With what we know about the timeline for the Lovenox trial, do you think NVS is giving serious consideration to acquiring MNTA sooner than later? It seems like if they wait too long, a nice stream of good news out of Momenta is going to make them much pricier. Or do you think the Alcon acquisition has tempered their M&A fever in the short term?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.